Mesirow Financial Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-48,711
| Closed | -$195K | – | 81 |
|
2021
Q4 | $195K | Hold |
48,711
| – | – | 0.56% | 70 |
|
2021
Q3 | $428K | Sell |
48,711
-1,351
| -3% | -$11.9K | 1.26% | 44 |
|
2021
Q2 | $567K | Sell |
50,062
-13,572
| -21% | -$154K | 1.45% | 24 |
|
2021
Q1 | $756K | Sell |
63,634
-1,064
| -2% | -$12.6K | 2.06% | 3 |
|
2020
Q4 | $444K | Buy |
64,698
+307
| +0.5% | +$2.11K | 1.4% | 26 |
|
2020
Q3 | $477K | Sell |
64,391
-27,175
| -30% | -$201K | 2.04% | 3 |
|
2020
Q2 | $382K | Sell |
91,566
-2,297
| -2% | -$9.58K | 1.8% | 10 |
|
2020
Q1 | $232K | Buy |
93,863
+27,014
| +40% | +$66.8K | 1.46% | 45 |
|
2019
Q4 | $388K | Sell |
66,849
-2,180
| -3% | -$12.7K | 1.64% | 29 |
|
2019
Q3 | $364K | Buy |
69,029
+6,293
| +10% | +$33.2K | 1.53% | 39 |
|
2019
Q2 | $373K | Buy |
62,736
+6,775
| +12% | +$40.3K | 1.36% | 47 |
|
2019
Q1 | $505K | Buy |
55,961
+17,864
| +47% | +$161K | 2.01% | 16 |
|
2018
Q4 | $316K | Hold |
38,097
| – | – | 2.04% | 19 |
|
2018
Q3 | $526K | Sell |
38,097
-3,031
| -7% | -$41.8K | 2.71% | 4 |
|
2018
Q2 | $327K | Buy |
+41,128
| New | +$327K | 1.45% | 40 |
|